Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression

Cancer Research

Volumn 64, Issue 15, 2004, Pages 5068-5073

  Somasiri, Aruna ^a   Nielsen, Julie S ^a   Makretsov, Nikita ^b   McCoy, Marcia L ^a   Prentice, Leah ^b   Gilks, C Blake ^b   Chia, Stephen K ^c   Gelmon, Karen A ^c   Kershaw, David B ^d   Huntsman, David G ^b   McNagny, Kelly M ^a   Roskelley, Calvin D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PODOCALYXIN;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL JUNCTION; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MONOLAYER CULTURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL ADHESION; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR JUNCTIONS; LYMPHATIC METASTASIS; PROGNOSIS; SIALOGLYCOPROTEINS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 3442882797     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0240     Document Type: Article

References (20)

1. Cleton-Jansen AM. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res 2002;4:5-8.
2. Kerjaschki D, Sharkey DJ, Farquhar MG. Identification and characterization of podocalyxin-the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 1984;98:1591-6.
3. Kershaw DB, Thomas PE, Wharram BL, et al. Molecular cloning, expression, and characterization of podocalyxin-like protein I from rabbit as a transmembrane protein of glomerular podocytes and vascular endothelium. J Biol Chem 1985:270:29439-46.
4. McNagny KM, Pettersson I, Rossi F, et al. Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors. J Cell Biol 1997;138:1395-1407.
5. Takeda T, Go WY, Orlando RA, Farquhar MG. Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby Canine Kidney Cells. Mol Biol Cell 2000;11:3219-32.
6. Makretsov N, Gilks B, Coldman A, Hayes M, Huntsman D. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum Pathol 2003;34:1001-3.
7. Parker RL, Huntsman DG, Lesack DW, et al. Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. Am J Clin Pathol 2002;117:723-8.
8. Kershaw DB, Beck SG, Wharram BL, et al. Molecular cloning and characterization of human podocalyxin-like protein. J Biol Chem 1997;272:15708-14.
9. Liu CL, Prapong W, Natkuman Y, et al. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 2002;161:1557-64.
10. Doyonnas R, Kershaw DB, Duhme C, et al. Anuria, omphalocele, and perinatal lethality in mice lacking the CD-34-related protein podocalyxin. J Exp Med 2001;194:13-27.
11. Miettinen A, Solin ML, Reivinen J, Juvonen E, Vaisanen R, Holthofer H. Podocalyxin in rat platelets and megakaryocytes. Am J Pathol 1999;154:813-22.
12. van 't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond) 2002;415:530-6.
13. Sassetti C, Van Zante A, Rosen SD. Identification of endoglycan, a member of the CD34/podocalyxin family of sialomucins. J Biol Chem 2000;275:9001-10.
14. Schopperle WM, Kershaw DB, DeWolf WC. Human embryonal carcinoma antigen, Gp200/GCTM-2 is podocalyxin. Biochem Biophys Res Commun 2002;300:285-90.
15. Kershaw DB, Wiggins JE, Wharram BL, Wiggins RC. Assignment of the human podocalyxin-like protein (PODXL) gene to 7q32-q33. Genomics 1997;45:239-40.
16. Aubele M, Mattis A, Zitzelsberger H, et al. Extensive ductal carcinoma in situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH. Int J Cancer 2000;85:82-6.
17. Forozan F, Mahlamaki EH, Monni O, et al. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 2000;60:4519-25.
18. Ginger MR, Gonzalez-Rimbau MF, Gay JP, Rosen JM. Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol 2001;15:1993-2009.
19. Takeda T, McQuistran T, Orlando RA, Farquhar MG. Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J Clin Investig 2001;108:289-301.
20. Stemmer-Rachamimov AO, Wiederhold T, Nielsen GP et al. NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. Am J Pathol 2001;158:57-62.